Abstract
Mesenchymal stromal cells (MSCs) have generated interest because of their therapeutic potential in cellular therapy, tissue engineering, and drug delivery (e.g., [1]). Since MSCs can be isolated from many different tissues and from tissues at different time throughout the life of the individual, and since MSCs can be derived from discarded tissues such as umbilical cord or placenta, or from adipose tissue following liposuction, the question arises: What source of MSCs will serve best for these different applications?
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
